 Robert Ryu
Concepts (501)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vena Cava Filters | 24 | 2023 | 64 | 6.330 |
Why?
| | Embolization, Therapeutic | 44 | 2020 | 245 | 3.220 |
Why?
| | Liver Neoplasms | 60 | 2014 | 758 | 3.130 |
Why?
| | Device Removal | 18 | 2023 | 143 | 3.100 |
Why?
| | Yttrium Radioisotopes | 40 | 2020 | 63 | 2.800 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 10 | 2021 | 38 | 2.780 |
Why?
| | Carcinoma, Hepatocellular | 41 | 2014 | 365 | 2.450 |
Why?
| | Radiology, Interventional | 6 | 2024 | 49 | 2.360 |
Why?
| | Pulmonary Embolism | 11 | 2021 | 239 | 1.820 |
Why?
| | Radiography, Interventional | 17 | 2016 | 129 | 1.570 |
Why?
| | Esophageal and Gastric Varices | 4 | 2021 | 35 | 1.500 |
Why?
| | Chemoembolization, Therapeutic | 21 | 2014 | 89 | 1.460 |
Why?
| | Hypertension, Portal | 5 | 2016 | 65 | 1.290 |
Why?
| | Radiopharmaceuticals | 19 | 2020 | 191 | 1.270 |
Why?
| | Lumbar Vertebrae | 4 | 2021 | 252 | 1.220 |
Why?
| | Uterine Neoplasms | 11 | 2010 | 96 | 1.110 |
Why?
| | Vena Cava, Inferior | 7 | 2021 | 74 | 1.010 |
Why?
| | Educational Measurement | 2 | 2020 | 324 | 0.990 |
Why?
| | Venous Thrombosis | 6 | 2023 | 194 | 0.960 |
Why?
| | Lasers, Excimer | 2 | 2022 | 30 | 0.920 |
Why?
| | Renal Dialysis | 2 | 2020 | 460 | 0.890 |
Why?
| | Treatment Outcome | 71 | 2023 | 11365 | 0.890 |
Why?
| | Portal Vein | 4 | 2016 | 111 | 0.880 |
Why?
| | Practice Patterns, Physicians' | 9 | 2021 | 1362 | 0.870 |
Why?
| | Microspheres | 29 | 2013 | 142 | 0.860 |
Why?
| | Prosthesis Design | 7 | 2020 | 352 | 0.820 |
Why?
| | Magnetic Resonance Imaging, Interventional | 8 | 2014 | 27 | 0.790 |
Why?
| | Specialty Boards | 2 | 2020 | 41 | 0.770 |
Why?
| | Leiomyoma | 9 | 2007 | 58 | 0.770 |
Why?
| | Total Disc Replacement | 2 | 2020 | 14 | 0.770 |
Why?
| | Intervertebral Disc | 3 | 2020 | 37 | 0.750 |
Why?
| | Uterus | 7 | 2007 | 221 | 0.740 |
Why?
| | Postoperative Complications | 8 | 2021 | 2887 | 0.740 |
Why?
| | End Stage Liver Disease | 2 | 2021 | 85 | 0.730 |
Why?
| | Forecasting | 1 | 2024 | 384 | 0.730 |
Why?
| | Venous Insufficiency | 3 | 2007 | 12 | 0.700 |
Why?
| | Saphenous Vein | 3 | 2007 | 37 | 0.690 |
Why?
| | Thromboembolism | 3 | 2017 | 126 | 0.670 |
Why?
| | Middle Aged | 87 | 2026 | 35342 | 0.640 |
Why?
| | Medicare | 3 | 2020 | 811 | 0.640 |
Why?
| | Spinal Fusion | 3 | 2021 | 260 | 0.630 |
Why?
| | Humans | 152 | 2026 | 143560 | 0.630 |
Why?
| | Prosthesis Implantation | 3 | 2017 | 156 | 0.620 |
Why?
| | Intervertebral Disc Displacement | 1 | 2020 | 41 | 0.610 |
Why?
| | Laser Therapy | 3 | 2007 | 131 | 0.610 |
Why?
| | Diagnostic Imaging | 4 | 2024 | 333 | 0.610 |
Why?
| | Cerebrospinal Fluid Leak | 1 | 2020 | 65 | 0.600 |
Why?
| | Graft Occlusion, Vascular | 2 | 2018 | 39 | 0.580 |
Why?
| | Medicine | 1 | 2020 | 125 | 0.580 |
Why?
| | Magnetic Resonance Angiography | 10 | 2014 | 251 | 0.570 |
Why?
| | Endovascular Procedures | 5 | 2020 | 375 | 0.570 |
Why?
| | Low Back Pain | 1 | 2020 | 109 | 0.560 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2018 | 19 | 0.550 |
Why?
| | Venous Thromboembolism | 4 | 2017 | 337 | 0.540 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 3 | 2019 | 214 | 0.530 |
Why?
| | Ultrasonography, Interventional | 3 | 2016 | 158 | 0.530 |
Why?
| | Spine | 1 | 2019 | 179 | 0.530 |
Why?
| | Female | 103 | 2026 | 77251 | 0.520 |
Why?
| | Ascites | 2 | 2016 | 49 | 0.510 |
Why?
| | Time Factors | 25 | 2021 | 7031 | 0.510 |
Why?
| | Magnetic Resonance Imaging | 27 | 2023 | 3798 | 0.510 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2017 | 68 | 0.510 |
Why?
| | Gastrointestinal Hemorrhage | 4 | 2021 | 137 | 0.500 |
Why?
| | Aged | 64 | 2026 | 25322 | 0.490 |
Why?
| | Stents | 8 | 2015 | 543 | 0.490 |
Why?
| | Tomography, X-Ray Computed | 25 | 2026 | 2779 | 0.490 |
Why?
| | Orthopedic Procedures | 1 | 2019 | 233 | 0.490 |
Why?
| | Retrospective Studies | 37 | 2023 | 16741 | 0.480 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2016 | 33 | 0.470 |
Why?
| | Digestive System Neoplasms | 1 | 2015 | 9 | 0.470 |
Why?
| | Aged, 80 and over | 34 | 2021 | 8072 | 0.460 |
Why?
| | Brachytherapy | 8 | 2008 | 131 | 0.460 |
Why?
| | Male | 88 | 2026 | 71500 | 0.450 |
Why?
| | Cholestasis | 2 | 2015 | 217 | 0.440 |
Why?
| | Adult | 59 | 2021 | 40013 | 0.440 |
Why?
| | Social Media | 1 | 2017 | 166 | 0.430 |
Why?
| | United States | 17 | 2026 | 15553 | 0.430 |
Why?
| | Radiology | 2 | 2024 | 172 | 0.410 |
Why?
| | Radiation Dosage | 6 | 2020 | 195 | 0.400 |
Why?
| | Liver Neoplasms, Experimental | 4 | 2020 | 29 | 0.380 |
Why?
| | Thrombosis | 4 | 2022 | 401 | 0.370 |
Why?
| | Clinical Competence | 2 | 2019 | 1235 | 0.370 |
Why?
| | Ovary | 3 | 2003 | 227 | 0.370 |
Why?
| | Angiography | 11 | 2011 | 207 | 0.350 |
Why?
| | Imaging, Three-Dimensional | 5 | 2011 | 569 | 0.350 |
Why?
| | Liver Cirrhosis | 6 | 2019 | 285 | 0.340 |
Why?
| | Risk Factors | 18 | 2020 | 10644 | 0.330 |
Why?
| | Uterine Artery Embolization | 1 | 2010 | 8 | 0.320 |
Why?
| | Vascular System Injuries | 3 | 2016 | 77 | 0.320 |
Why?
| | Cholangiocarcinoma | 4 | 2013 | 100 | 0.320 |
Why?
| | Perfusion Imaging | 1 | 2010 | 63 | 0.320 |
Why?
| | Endoscopy, Gastrointestinal | 3 | 2021 | 233 | 0.310 |
Why?
| | Drainage | 3 | 2019 | 182 | 0.310 |
Why?
| | Angioplasty | 3 | 2007 | 48 | 0.310 |
Why?
| | Adenoma, Islet Cell | 1 | 2009 | 6 | 0.310 |
Why?
| | Chicago | 6 | 2017 | 66 | 0.310 |
Why?
| | Aortic Aneurysm, Abdominal | 3 | 2007 | 163 | 0.310 |
Why?
| | Liver Abscess | 1 | 2009 | 5 | 0.310 |
Why?
| | Predictive Value of Tests | 11 | 2020 | 2086 | 0.300 |
Why?
| | Thyroid Gland | 1 | 2009 | 93 | 0.300 |
Why?
| | Polyvinyl Alcohol | 3 | 2005 | 18 | 0.300 |
Why?
| | Observer Variation | 3 | 2010 | 361 | 0.300 |
Why?
| | Hepatic Veins | 1 | 2008 | 31 | 0.290 |
Why?
| | Rabbits | 12 | 2020 | 665 | 0.290 |
Why?
| | Phlebography | 6 | 2015 | 39 | 0.290 |
Why?
| | Neoplasms | 5 | 2023 | 2804 | 0.280 |
Why?
| | Contrast Media | 12 | 2016 | 479 | 0.280 |
Why?
| | Neovascularization, Pathologic | 5 | 2009 | 295 | 0.280 |
Why?
| | Portography | 4 | 2016 | 7 | 0.280 |
Why?
| | Gelatin | 2 | 2005 | 57 | 0.280 |
Why?
| | Liver Transplantation | 5 | 2015 | 814 | 0.270 |
Why?
| | Lymphangioma, Cystic | 1 | 2007 | 5 | 0.270 |
Why?
| | Databases, Factual | 7 | 2020 | 1465 | 0.260 |
Why?
| | Patient Selection | 6 | 2020 | 691 | 0.260 |
Why?
| | Prosthesis Failure | 3 | 2017 | 125 | 0.260 |
Why?
| | Catheterization | 7 | 2013 | 185 | 0.260 |
Why?
| | Aortography | 1 | 2007 | 54 | 0.260 |
Why?
| | Pancreatic Neoplasms | 3 | 2010 | 924 | 0.250 |
Why?
| | Antineoplastic Agents | 6 | 2014 | 2195 | 0.250 |
Why?
| | Hepatic Artery | 5 | 2010 | 52 | 0.250 |
Why?
| | Logistic Models | 8 | 2021 | 2107 | 0.250 |
Why?
| | Linear Models | 4 | 2017 | 858 | 0.250 |
Why?
| | Thrombolytic Therapy | 4 | 2023 | 157 | 0.250 |
Why?
| | Referral and Consultation | 1 | 2012 | 828 | 0.250 |
Why?
| | Bile Duct Neoplasms | 4 | 2013 | 121 | 0.240 |
Why?
| | Thyroid Neoplasms | 1 | 2009 | 337 | 0.230 |
Why?
| | Acrylic Resins | 1 | 2005 | 48 | 0.230 |
Why?
| | Radiation Injuries | 5 | 2010 | 149 | 0.220 |
Why?
| | Blood Vessel Prosthesis Implantation | 2 | 2007 | 222 | 0.220 |
Why?
| | Blister | 1 | 2004 | 40 | 0.210 |
Why?
| | Arteries | 7 | 2013 | 261 | 0.210 |
Why?
| | Multivariate Analysis | 7 | 2017 | 1510 | 0.210 |
Why?
| | Prospective Studies | 17 | 2026 | 7899 | 0.210 |
Why?
| | Survival Rate | 12 | 2018 | 2003 | 0.210 |
Why?
| | Internship and Residency | 2 | 2019 | 1250 | 0.200 |
Why?
| | Cohort Studies | 7 | 2023 | 5891 | 0.200 |
Why?
| | Postphlebitic Syndrome | 1 | 2023 | 2 | 0.200 |
Why?
| | Postthrombotic Syndrome | 1 | 2023 | 13 | 0.200 |
Why?
| | Jugular Veins | 3 | 1997 | 42 | 0.200 |
Why?
| | Neoplasm Staging | 8 | 2014 | 1416 | 0.190 |
Why?
| | Fluoroscopy | 2 | 2016 | 171 | 0.180 |
Why?
| | Elasticity Imaging Techniques | 1 | 2022 | 59 | 0.180 |
Why?
| | Education, Medical, Continuing | 2 | 2017 | 128 | 0.180 |
Why?
| | Catheters | 3 | 2023 | 74 | 0.180 |
Why?
| | Neoplasms, Experimental | 2 | 2013 | 174 | 0.180 |
Why?
| | Clinical Trials as Topic | 3 | 2013 | 1043 | 0.180 |
Why?
| | Kaplan-Meier Estimate | 9 | 2015 | 921 | 0.180 |
Why?
| | Chi-Square Distribution | 6 | 2014 | 527 | 0.180 |
Why?
| | Disease Progression | 14 | 2014 | 2856 | 0.170 |
Why?
| | Constriction, Pathologic | 3 | 2019 | 246 | 0.170 |
Why?
| | Vascular Patency | 3 | 2018 | 112 | 0.170 |
Why?
| | Bone-Implant Interface | 1 | 2021 | 3 | 0.170 |
Why?
| | Angiography, Digital Subtraction | 6 | 2014 | 46 | 0.170 |
Why?
| | Liver | 7 | 2013 | 1864 | 0.170 |
Why?
| | Multicenter Studies as Topic | 1 | 2022 | 389 | 0.170 |
Why?
| | Ultrasonography, Doppler, Color | 3 | 2008 | 37 | 0.170 |
Why?
| | alpha-Fetoproteins | 2 | 2012 | 40 | 0.170 |
Why?
| | Reoperation | 4 | 2019 | 605 | 0.170 |
Why?
| | Early Detection of Cancer | 1 | 2026 | 445 | 0.170 |
Why?
| | Surgical Stomas | 1 | 2000 | 7 | 0.170 |
Why?
| | Catheter Ablation | 1 | 2004 | 341 | 0.160 |
Why?
| | Colostomy | 1 | 2000 | 28 | 0.160 |
Why?
| | Varicose Veins | 1 | 2000 | 16 | 0.160 |
Why?
| | Liver Diseases | 2 | 2007 | 304 | 0.160 |
Why?
| | Disease Models, Animal | 6 | 2016 | 4522 | 0.160 |
Why?
| | Medical Oncology | 2 | 2013 | 328 | 0.160 |
Why?
| | Adolescent | 16 | 2021 | 22481 | 0.160 |
Why?
| | Infusions, Intra-Arterial | 9 | 2010 | 62 | 0.160 |
Why?
| | Sensitivity and Specificity | 9 | 2012 | 1984 | 0.160 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2020 | 116 | 0.150 |
Why?
| | Costs and Cost Analysis | 1 | 2020 | 220 | 0.150 |
Why?
| | Lumbosacral Region | 1 | 2020 | 62 | 0.150 |
Why?
| | Budd-Chiari Syndrome | 1 | 1999 | 5 | 0.150 |
Why?
| | Hepatorenal Syndrome | 1 | 2019 | 15 | 0.150 |
Why?
| | Laminoplasty | 1 | 2019 | 2 | 0.150 |
Why?
| | Laminectomy | 1 | 2019 | 32 | 0.150 |
Why?
| | Image Interpretation, Computer-Assisted | 3 | 2011 | 277 | 0.150 |
Why?
| | Follow-Up Studies | 11 | 2013 | 5308 | 0.150 |
Why?
| | Bile Ducts | 1 | 2019 | 67 | 0.150 |
Why?
| | Ohio | 1 | 2019 | 140 | 0.150 |
Why?
| | Iliac Artery | 2 | 2018 | 57 | 0.150 |
Why?
| | Specialization | 1 | 2020 | 135 | 0.150 |
Why?
| | Glass | 3 | 2013 | 46 | 0.150 |
Why?
| | Hemorrhage | 2 | 2023 | 804 | 0.150 |
Why?
| | Robotic Surgical Procedures | 1 | 2021 | 154 | 0.150 |
Why?
| | Models, Educational | 1 | 2019 | 95 | 0.140 |
Why?
| | Survival Analysis | 6 | 2011 | 1332 | 0.140 |
Why?
| | Young Adult | 8 | 2021 | 13972 | 0.140 |
Why?
| | Biliary Fistula | 1 | 1998 | 4 | 0.140 |
Why?
| | Urinary Fistula | 1 | 1998 | 9 | 0.140 |
Why?
| | Diffusion Magnetic Resonance Imaging | 2 | 2010 | 156 | 0.140 |
Why?
| | Intestine, Small | 1 | 2019 | 159 | 0.140 |
Why?
| | Mesenteric Veins | 1 | 1998 | 23 | 0.140 |
Why?
| | Fibrin | 2 | 2023 | 90 | 0.140 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 272 | 0.140 |
Why?
| | Pain | 1 | 2003 | 781 | 0.130 |
Why?
| | Writing | 1 | 2019 | 99 | 0.130 |
Why?
| | Thrombectomy | 1 | 1998 | 78 | 0.130 |
Why?
| | United States Food and Drug Administration | 2 | 2017 | 202 | 0.130 |
Why?
| | Liver Circulation | 4 | 2015 | 12 | 0.130 |
Why?
| | Radiography | 7 | 2012 | 846 | 0.130 |
Why?
| | Longitudinal Studies | 2 | 2026 | 3006 | 0.130 |
Why?
| | Treatment Failure | 4 | 2017 | 357 | 0.130 |
Why?
| | Patient Advocacy | 1 | 2017 | 75 | 0.130 |
Why?
| | Drug Utilization | 1 | 2017 | 166 | 0.120 |
Why?
| | Vena Cava, Superior | 1 | 2016 | 24 | 0.120 |
Why?
| | Hemostasis, Surgical | 1 | 2016 | 27 | 0.120 |
Why?
| | Portal Pressure | 1 | 2016 | 4 | 0.120 |
Why?
| | Hospitals | 1 | 2021 | 691 | 0.120 |
Why?
| | History, 20th Century | 1 | 2017 | 327 | 0.120 |
Why?
| | Severity of Illness Index | 2 | 2021 | 2936 | 0.120 |
Why?
| | Anatomic Landmarks | 1 | 2016 | 31 | 0.120 |
Why?
| | Academic Medical Centers | 1 | 2019 | 535 | 0.120 |
Why?
| | Balloon Occlusion | 1 | 2016 | 39 | 0.120 |
Why?
| | Research Design | 3 | 2013 | 1123 | 0.120 |
Why?
| | Finite Element Analysis | 1 | 2016 | 75 | 0.120 |
Why?
| | Gadolinium DTPA | 5 | 2014 | 71 | 0.120 |
Why?
| | Lower Extremity | 1 | 2020 | 444 | 0.120 |
Why?
| | Patient Readmission | 1 | 2021 | 706 | 0.120 |
Why?
| | Models, Anatomic | 1 | 2016 | 86 | 0.120 |
Why?
| | Stomach | 2 | 2013 | 117 | 0.120 |
Why?
| | Reproducibility of Results | 8 | 2011 | 3380 | 0.110 |
Why?
| | Cell Line, Tumor | 7 | 2013 | 3611 | 0.110 |
Why?
| | Operative Time | 1 | 2016 | 163 | 0.110 |
Why?
| | Doxorubicin | 3 | 2013 | 381 | 0.110 |
Why?
| | Radiation Exposure | 1 | 2016 | 61 | 0.110 |
Why?
| | Aorta | 1 | 2018 | 433 | 0.110 |
Why?
| | Biomarkers, Tumor | 4 | 2026 | 1282 | 0.110 |
Why?
| | Bile Ducts, Intrahepatic | 3 | 2013 | 61 | 0.110 |
Why?
| | Wounds, Nonpenetrating | 4 | 2000 | 312 | 0.110 |
Why?
| | Hospital Mortality | 2 | 2018 | 962 | 0.110 |
Why?
| | Necrosis | 5 | 2020 | 247 | 0.110 |
Why?
| | Dilatation | 1 | 2015 | 71 | 0.110 |
Why?
| | Intraoperative Complications | 1 | 2016 | 155 | 0.110 |
Why?
| | Sex Factors | 2 | 2018 | 2092 | 0.110 |
Why?
| | Biopsy | 3 | 2014 | 1083 | 0.110 |
Why?
| | Carotid Artery Injuries | 3 | 2000 | 40 | 0.110 |
Why?
| | Cisplatin | 3 | 2012 | 333 | 0.110 |
Why?
| | Data Interpretation, Statistical | 3 | 2013 | 377 | 0.110 |
Why?
| | Foreign-Body Migration | 1 | 2014 | 32 | 0.110 |
Why?
| | Wounds, Gunshot | 1 | 1998 | 251 | 0.110 |
Why?
| | Carbon Dioxide | 1 | 2016 | 242 | 0.100 |
Why?
| | Education, Medical, Graduate | 1 | 2019 | 541 | 0.100 |
Why?
| | Length of Stay | 2 | 2019 | 1279 | 0.100 |
Why?
| | Kidney Diseases | 1 | 1998 | 412 | 0.100 |
Why?
| | Stress, Mechanical | 1 | 2016 | 496 | 0.100 |
Why?
| | Magnetite Nanoparticles | 1 | 2013 | 28 | 0.100 |
Why?
| | Duodenum | 1 | 2013 | 77 | 0.100 |
Why?
| | Ultrasonography | 3 | 2022 | 769 | 0.100 |
Why?
| | Peripheral Arterial Disease | 1 | 2020 | 498 | 0.100 |
Why?
| | Arthroscopy | 3 | 1992 | 245 | 0.100 |
Why?
| | Anticoagulants | 2 | 2017 | 728 | 0.100 |
Why?
| | Prevalence | 3 | 2021 | 2830 | 0.100 |
Why?
| | Regional Blood Flow | 3 | 2007 | 504 | 0.090 |
Why?
| | Catheterization, Peripheral | 3 | 2008 | 116 | 0.090 |
Why?
| | Lung Neoplasms | 1 | 2026 | 2580 | 0.090 |
Why?
| | Biomechanical Phenomena | 1 | 2016 | 867 | 0.090 |
Why?
| | Proportional Hazards Models | 5 | 2014 | 1292 | 0.090 |
Why?
| | Patient Education as Topic | 1 | 2017 | 783 | 0.090 |
Why?
| | Shoulder Injuries | 1 | 1992 | 59 | 0.090 |
Why?
| | Acromion | 1 | 1992 | 8 | 0.090 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 1827 | 0.090 |
Why?
| | Electroporation | 1 | 2012 | 40 | 0.090 |
Why?
| | Tendon Injuries | 1 | 1992 | 69 | 0.090 |
Why?
| | Respiratory-Gated Imaging Techniques | 1 | 2011 | 10 | 0.090 |
Why?
| | Fibromuscular Dysplasia | 1 | 2011 | 9 | 0.090 |
Why?
| | Rotator Cuff | 1 | 1992 | 47 | 0.090 |
Why?
| | Comorbidity | 1 | 2016 | 1678 | 0.080 |
Why?
| | Prognosis | 5 | 2010 | 4152 | 0.080 |
Why?
| | Animals | 15 | 2021 | 38010 | 0.080 |
Why?
| | Yttrium | 1 | 2010 | 5 | 0.080 |
Why?
| | Research Report | 1 | 2011 | 81 | 0.080 |
Why?
| | Injections, Intra-Arterial | 5 | 2012 | 26 | 0.080 |
Why?
| | Surgery, Computer-Assisted | 1 | 2011 | 83 | 0.080 |
Why?
| | Tumor Burden | 3 | 2020 | 319 | 0.080 |
Why?
| | Neuroendocrine Tumors | 1 | 2011 | 112 | 0.080 |
Why?
| | Punctures | 1 | 2010 | 40 | 0.080 |
Why?
| | Practice Guidelines as Topic | 5 | 2013 | 1557 | 0.080 |
Why?
| | Decision Support Techniques | 1 | 2014 | 438 | 0.080 |
Why?
| | Biopsy, Fine-Needle | 1 | 2009 | 70 | 0.080 |
Why?
| | Recurrence | 3 | 2021 | 1114 | 0.070 |
Why?
| | Pancreatic Pseudocyst | 1 | 2009 | 17 | 0.070 |
Why?
| | Bilirubin | 3 | 2010 | 91 | 0.070 |
Why?
| | Gastrostomy | 2 | 2009 | 133 | 0.070 |
Why?
| | Liver Function Tests | 3 | 2015 | 107 | 0.070 |
Why?
| | Radiation Pneumonitis | 1 | 2008 | 31 | 0.070 |
Why?
| | Breast Neoplasms | 2 | 2014 | 2318 | 0.070 |
Why?
| | Ambulatory Care Facilities | 1 | 2010 | 250 | 0.070 |
Why?
| | Biliary Tract | 1 | 2008 | 14 | 0.070 |
Why?
| | Radiotherapy Dosage | 4 | 2010 | 280 | 0.070 |
Why?
| | Knee Injuries | 1 | 1989 | 103 | 0.070 |
Why?
| | Maximum Allowable Concentration | 1 | 2007 | 16 | 0.070 |
Why?
| | Subtraction Technique | 1 | 2007 | 25 | 0.070 |
Why?
| | Palliative Care | 1 | 2015 | 852 | 0.070 |
Why?
| | Neoplasm Transplantation | 1 | 2008 | 253 | 0.070 |
Why?
| | Diagnosis, Differential | 3 | 2009 | 1504 | 0.070 |
Why?
| | Endpoint Determination | 3 | 2013 | 78 | 0.070 |
Why?
| | Vacuum Curettage | 1 | 2007 | 5 | 0.070 |
Why?
| | Acute Disease | 2 | 2021 | 1015 | 0.070 |
Why?
| | Ultrasonography, Doppler, Duplex | 2 | 2004 | 40 | 0.070 |
Why?
| | Diagnostic Errors | 1 | 2008 | 177 | 0.060 |
Why?
| | Incidence | 3 | 2009 | 2844 | 0.060 |
Why?
| | Image Enhancement | 4 | 2011 | 194 | 0.060 |
Why?
| | Radiotherapy | 1 | 2008 | 206 | 0.060 |
Why?
| | Leiomyomatosis | 1 | 2006 | 4 | 0.060 |
Why?
| | Credentialing | 1 | 2006 | 21 | 0.060 |
Why?
| | Catheterization, Central Venous | 2 | 1999 | 117 | 0.060 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 296 | 0.060 |
Why?
| | Quality Assurance, Health Care | 1 | 2008 | 322 | 0.060 |
Why?
| | France | 1 | 2026 | 40 | 0.060 |
Why?
| | Iron | 1 | 2008 | 345 | 0.060 |
Why?
| | Fluorescent Dyes | 1 | 2007 | 325 | 0.060 |
Why?
| | Ethics, Research | 1 | 2005 | 30 | 0.060 |
Why?
| | Personnel Selection | 1 | 2006 | 88 | 0.060 |
Why?
| | Knee Joint | 1 | 1989 | 413 | 0.060 |
Why?
| | Hospitalization | 3 | 2021 | 2313 | 0.060 |
Why?
| | Organ Size | 3 | 2013 | 481 | 0.060 |
Why?
| | Heart Failure | 1 | 2018 | 2131 | 0.060 |
Why?
| | Decision Making | 1 | 2012 | 962 | 0.060 |
Why?
| | Postmenopause | 1 | 2007 | 377 | 0.050 |
Why?
| | Kidney Transplantation | 1 | 2011 | 698 | 0.050 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 2 | 2020 | 121 | 0.050 |
Why?
| | Combined Modality Therapy | 2 | 2017 | 1252 | 0.050 |
Why?
| | Odds Ratio | 2 | 2017 | 1060 | 0.050 |
Why?
| | Dose-Response Relationship, Radiation | 3 | 2008 | 143 | 0.050 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2003 | 16 | 0.050 |
Why?
| | Pilot Projects | 4 | 2009 | 1838 | 0.050 |
Why?
| | Ischemia | 1 | 2006 | 416 | 0.050 |
Why?
| | Iliac Vein | 1 | 2023 | 15 | 0.050 |
Why?
| | Illinois | 3 | 2009 | 45 | 0.050 |
Why?
| | Femoral Vein | 1 | 2023 | 38 | 0.050 |
Why?
| | Fellowships and Scholarships | 1 | 2006 | 333 | 0.050 |
Why?
| | Aneurysm, False | 2 | 2000 | 45 | 0.050 |
Why?
| | Menisci, Tibial | 2 | 1995 | 63 | 0.050 |
Why?
| | Watchful Waiting | 1 | 2023 | 88 | 0.050 |
Why?
| | Elasticity | 1 | 2022 | 193 | 0.050 |
Why?
| | Pelvis | 1 | 2002 | 121 | 0.040 |
Why?
| | Drug Stability | 2 | 2013 | 165 | 0.040 |
Why?
| | Confidence Intervals | 2 | 2013 | 332 | 0.040 |
Why?
| | World Health Organization | 2 | 2012 | 103 | 0.040 |
Why?
| | Hepatectomy | 2 | 2013 | 258 | 0.040 |
Why?
| | Colorectal Neoplasms | 1 | 2009 | 833 | 0.040 |
Why?
| | Feasibility Studies | 3 | 2011 | 1051 | 0.040 |
Why?
| | X-Ray Microtomography | 1 | 2021 | 106 | 0.040 |
Why?
| | Osseointegration | 1 | 2021 | 71 | 0.040 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2021 | 60 | 0.040 |
Why?
| | Europe | 2 | 2012 | 410 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2023 | 623 | 0.040 |
Why?
| | Allografts | 1 | 2021 | 151 | 0.040 |
Why?
| | Administrative Claims, Healthcare | 1 | 2020 | 26 | 0.040 |
Why?
| | Mice, SCID | 1 | 2021 | 372 | 0.040 |
Why?
| | Carotid Artery, Internal | 1 | 2000 | 44 | 0.040 |
Why?
| | Neural Crest | 1 | 2021 | 121 | 0.040 |
Why?
| | Cardiologists | 1 | 2020 | 46 | 0.040 |
Why?
| | Disease-Free Survival | 2 | 2013 | 720 | 0.040 |
Why?
| | Skull | 1 | 2021 | 152 | 0.040 |
Why?
| | Bone Marrow Cells | 1 | 2021 | 319 | 0.040 |
Why?
| | Radiologists | 1 | 2020 | 62 | 0.040 |
Why?
| | Hepatic Encephalopathy | 1 | 1999 | 25 | 0.040 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2020 | 77 | 0.040 |
Why?
| | Menstrual Cycle | 1 | 2000 | 139 | 0.040 |
Why?
| | Evidence-Based Medicine | 2 | 2013 | 724 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2021 | 607 | 0.040 |
Why?
| | Tomography, Emission-Computed | 2 | 2009 | 68 | 0.040 |
Why?
| | Tracheoesophageal Fistula | 1 | 1999 | 37 | 0.040 |
Why?
| | Liver Failure | 1 | 1999 | 82 | 0.040 |
Why?
| | Anastomosis, Surgical | 1 | 2019 | 159 | 0.040 |
Why?
| | Multiple Organ Failure | 1 | 1999 | 127 | 0.040 |
Why?
| | Streptokinase | 1 | 1998 | 9 | 0.040 |
Why?
| | Analysis of Variance | 2 | 2011 | 1314 | 0.040 |
Why?
| | Serum Albumin | 1 | 1999 | 150 | 0.040 |
Why?
| | Equipment Design | 2 | 2012 | 533 | 0.040 |
Why?
| | Ethiodized Oil | 2 | 2008 | 9 | 0.040 |
Why?
| | Postoperative Hemorrhage | 1 | 1999 | 90 | 0.040 |
Why?
| | Mitomycin | 2 | 2008 | 34 | 0.030 |
Why?
| | Swine | 2 | 2016 | 837 | 0.030 |
Why?
| | Guidelines as Topic | 2 | 2010 | 270 | 0.030 |
Why?
| | Population Surveillance | 1 | 2001 | 488 | 0.030 |
Why?
| | Nervous System Diseases | 2 | 2017 | 280 | 0.030 |
Why?
| | Cartilage Diseases | 2 | 1995 | 45 | 0.030 |
Why?
| | Intracranial Hypertension | 1 | 1997 | 41 | 0.030 |
Why?
| | Cause of Death | 1 | 1999 | 459 | 0.030 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 1997 | 128 | 0.030 |
Why?
| | Abdominal Injuries | 1 | 1998 | 124 | 0.030 |
Why?
| | Tuberculosis, Pulmonary | 1 | 1997 | 130 | 0.030 |
Why?
| | Demography | 1 | 2017 | 297 | 0.030 |
Why?
| | Radiography, Thoracic | 1 | 1997 | 180 | 0.030 |
Why?
| | Positron-Emission Tomography | 2 | 2008 | 310 | 0.030 |
Why?
| | Databases as Topic | 2 | 2010 | 69 | 0.030 |
Why?
| | Recovery of Function | 1 | 2000 | 702 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2003 | 3625 | 0.030 |
Why?
| | Fibrinolytic Agents | 1 | 1998 | 287 | 0.030 |
Why?
| | Surgeons | 1 | 2020 | 336 | 0.030 |
Why?
| | Lung | 1 | 2008 | 4101 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2020 | 601 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2016 | 198 | 0.030 |
Why?
| | Inpatients | 1 | 2019 | 521 | 0.030 |
Why?
| | Phantoms, Imaging | 2 | 2008 | 152 | 0.030 |
Why?
| | Cysts | 1 | 1995 | 114 | 0.030 |
Why?
| | Embolism | 2 | 2008 | 46 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2017 | 557 | 0.030 |
Why?
| | Preoperative Care | 1 | 2016 | 380 | 0.030 |
Why?
| | Ablation Techniques | 1 | 2013 | 36 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2021 | 2020 | 0.020 |
Why?
| | Vascular Surgical Procedures | 1 | 2016 | 341 | 0.020 |
Why?
| | Eligibility Determination | 1 | 2013 | 70 | 0.020 |
Why?
| | Scapula | 1 | 1992 | 44 | 0.020 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2013 | 217 | 0.020 |
Why?
| | Nausea | 1 | 2011 | 112 | 0.020 |
Why?
| | Muscular Diseases | 1 | 1992 | 113 | 0.020 |
Why?
| | Vomiting | 1 | 2011 | 129 | 0.020 |
Why?
| | International Agencies | 1 | 2010 | 32 | 0.020 |
Why?
| | Biomarkers | 2 | 2014 | 4241 | 0.020 |
Why?
| | Clinical Trials, Phase II as Topic | 1 | 2010 | 75 | 0.020 |
Why?
| | Diarrhea | 1 | 2011 | 183 | 0.020 |
Why?
| | Abdominal Pain | 1 | 2011 | 144 | 0.020 |
Why?
| | Standard of Care | 1 | 2010 | 78 | 0.020 |
Why?
| | Neoadjuvant Therapy | 1 | 2013 | 438 | 0.020 |
Why?
| | Yttrium Isotopes | 1 | 2009 | 1 | 0.020 |
Why?
| | Risk Assessment | 2 | 2009 | 3577 | 0.020 |
Why?
| | Alkaline Phosphatase | 1 | 2010 | 147 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2010 | 317 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5743 | 0.020 |
Why?
| | Fatigue | 1 | 2011 | 349 | 0.020 |
Why?
| | Chronic Disease | 1 | 2015 | 1824 | 0.020 |
Why?
| | Range of Motion, Articular | 1 | 1992 | 415 | 0.020 |
Why?
| | Age Factors | 1 | 2017 | 3328 | 0.020 |
Why?
| | Registries | 1 | 2018 | 2238 | 0.020 |
Why?
| | Fibula | 1 | 1989 | 40 | 0.020 |
Why?
| | Ligaments, Articular | 1 | 1989 | 54 | 0.020 |
Why?
| | Terminology as Topic | 1 | 2011 | 250 | 0.020 |
Why?
| | ROC Curve | 1 | 2010 | 603 | 0.020 |
Why?
| | Rhenium | 1 | 2008 | 3 | 0.020 |
Why?
| | Radioisotopes | 1 | 2008 | 33 | 0.020 |
Why?
| | Iohexol | 1 | 2008 | 23 | 0.020 |
Why?
| | Body Burden | 1 | 2007 | 8 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2008 | 330 | 0.020 |
Why?
| | Hysterosalpingography | 1 | 2007 | 8 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2013 | 2531 | 0.020 |
Why?
| | Regression Analysis | 1 | 2010 | 1013 | 0.020 |
Why?
| | Tibia | 1 | 1989 | 188 | 0.020 |
Why?
| | Hindlimb | 1 | 2008 | 136 | 0.020 |
Why?
| | Injections | 1 | 2008 | 195 | 0.020 |
Why?
| | Mesenteric Arteries | 1 | 2007 | 18 | 0.020 |
Why?
| | Celiac Artery | 1 | 2007 | 20 | 0.020 |
Why?
| | Equipment Failure Analysis | 1 | 2007 | 131 | 0.020 |
Why?
| | Contraindications | 1 | 2007 | 86 | 0.020 |
Why?
| | Femur | 1 | 1989 | 271 | 0.020 |
Why?
| | Injury Severity Score | 2 | 2000 | 575 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2008 | 974 | 0.020 |
Why?
| | Weight Loss | 1 | 2011 | 811 | 0.010 |
Why?
| | Retreatment | 1 | 2005 | 75 | 0.010 |
Why?
| | Cartilage, Articular | 1 | 1989 | 333 | 0.010 |
Why?
| | Rats | 1 | 2013 | 5610 | 0.010 |
Why?
| | Neoplasm Metastasis | 1 | 2007 | 682 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2010 | 1671 | 0.010 |
Why?
| | Algorithms | 1 | 2011 | 1813 | 0.010 |
Why?
| | Mice | 1 | 2021 | 18378 | 0.010 |
Why?
| | Child | 3 | 2017 | 22725 | 0.010 |
Why?
| | Child, Preschool | 1 | 2017 | 11737 | 0.010 |
Why?
| | Radiography, Abdominal | 1 | 2001 | 44 | 0.010 |
Why?
| | Blood Flow Velocity | 1 | 2002 | 415 | 0.010 |
Why?
| | Models, Animal | 1 | 2002 | 392 | 0.010 |
Why?
| | Arteriosclerosis | 1 | 2000 | 83 | 0.010 |
Why?
| | Aorta, Abdominal | 1 | 2000 | 50 | 0.010 |
Why?
| | Pneumonia, Aspiration | 1 | 1999 | 17 | 0.010 |
Why?
| | Hematoma | 1 | 1999 | 55 | 0.010 |
Why?
| | Veins | 1 | 1999 | 70 | 0.010 |
Why?
| | Esophageal Stenosis | 1 | 1999 | 57 | 0.010 |
Why?
| | Aortic Diseases | 1 | 2000 | 120 | 0.010 |
Why?
| | Endoscopy | 1 | 2001 | 329 | 0.010 |
Why?
| | Decision Trees | 1 | 1998 | 81 | 0.010 |
Why?
| | Intubation, Gastrointestinal | 1 | 1999 | 79 | 0.010 |
Why?
| | Arm | 1 | 1999 | 109 | 0.010 |
Why?
| | Peripheral Nervous System Diseases | 1 | 1999 | 133 | 0.010 |
Why?
| | Cerebral Infarction | 1 | 1997 | 49 | 0.010 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 1997 | 69 | 0.010 |
Why?
| | Los Angeles | 1 | 1997 | 75 | 0.010 |
Why?
| | Carotid Artery Diseases | 1 | 1997 | 64 | 0.010 |
Why?
| | Neurologic Examination | 1 | 1997 | 127 | 0.010 |
Why?
| | Intracranial Pressure | 1 | 1997 | 61 | 0.010 |
Why?
| | Clinical Protocols | 1 | 1998 | 279 | 0.010 |
Why?
| | Glasgow Coma Scale | 1 | 1997 | 214 | 0.010 |
Why?
| | Multiple Trauma | 1 | 1997 | 118 | 0.010 |
Why?
| | Carotid Stenosis | 1 | 1997 | 99 | 0.010 |
Why?
| | Angioplasty, Balloon | 1 | 1997 | 94 | 0.010 |
Why?
| | Enteral Nutrition | 1 | 1999 | 220 | 0.010 |
Why?
| | Carotid Arteries | 1 | 1997 | 202 | 0.010 |
Why?
| | HIV | 1 | 1997 | 249 | 0.010 |
Why?
| | Heparin | 1 | 1997 | 254 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 1997 | 333 | 0.010 |
Why?
| | Cluster Analysis | 1 | 1997 | 526 | 0.010 |
Why?
| | Synovial Cyst | 1 | 1995 | 5 | 0.010 |
Why?
| | Craniocerebral Trauma | 1 | 1997 | 176 | 0.010 |
Why?
| | DNA, Viral | 1 | 1997 | 366 | 0.010 |
Why?
| | Brain Ischemia | 1 | 1997 | 351 | 0.010 |
Why?
| | Mycobacterium tuberculosis | 1 | 1997 | 332 | 0.010 |
Why?
| | Brain Injuries | 1 | 1997 | 506 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2002 | 6025 | 0.000 |
Why?
| | Tibial Meniscus Injuries | 1 | 1990 | 50 | 0.000 |
Why?
| | Postoperative Period | 1 | 1990 | 361 | 0.000 |
Why?
|
|
Ryu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|